Trial Profile
A retrospective cohort study investigating safety and efficacy of Simeprevir and Sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Oct 2016 New trial record